Biotech

All Articles

Pfizer, Valneva reveal lyme disease chance reliable for 2nd booster

.Pfizer as well as Valneva may possess about 2 even more years to hang around just before they creat...

Fierce Biotech Managing Editor Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Permit's study a conversation with Ayla Ellison, Strong Biotech Managing Editor and Michelle Benz a...

New information demonstrate how Bayer's asundexian failed to stop strokes

.Bayer put on hold the stage 3 trial for its variable XIa prevention asundexian behind time in 2013 ...

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS trials

.Sanofi is actually still set on taking its several sclerosis (MS) med tolebrutinib to the FDA, mana...

Galapagos' stock up as fund shows intent to mold its own advancement

.Galapagos is happening under added stress coming from financiers. Having developed a 9.9% concern i...

Cell- centered Sana gathers first CSO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of notable management hirings, shootings as w...

Allist pays off Jacobio $21M, landing task in Chinese KRAS race

.Shanghai Allist Pharmaceuticals has actually purchased itself a starring job in China's KRAS market...

ReNeuron leaving behind intention exchange after missing fundraising target

.ReNeuron has signed up with the long list of biotechs to leave behind Greater london's intention st...

MBX apply for IPO to take challenger to Ascendis into stage 3

.MBX Biosciences has contributed to the latest spurt of IPO filings. The biotech, which filed its ow...

FDA increases probe into Lykos' MDMA tests: WSJ

.For Lykos Therapies and the company's prospective MDMA-assisted therapy for trauma (POST-TRAUMATIC ...